SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Poly Medicure gains on getting nod for renewal of sales contract with Vitromed Healthcare

03 Apr 2014 Evaluate

Poly Medicure is currently trading at Rs. 471.85, up by 1.00 points or 0.21 % from its previous closing of Rs. 470.85 on the BSE.

The scrip opened at Rs. 468.00 and has touched a high and low of Rs. 472.00 and Rs. 468.00 respectively. So far 6464 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 477.00 on 28-Mar-2014 and a 52 week low of Rs. 215.00 on 04-Apr-2013.

Last one week high and low of the scrip stood at Rs. 477.00 and Rs. 395.20 respectively. The current market cap of the company is Rs. 1039.64 crore.

The promoters holding in the company stood at 48.68 % while Non-Institutions held 51.32% of the stake.

Poly Medicure has received an approval for renewal of sales contract with Vitromed Healthcare, Jaipur, for sale of Medical Devices and/or component(s) thereof, for the period of three years. The board of directors at its meeting held on April 01, 2014 have approved for the same.

The board also approved to take land & building from Vitromed Healthcare, Jaipur, on lease, for manufacturing activities of Medical Devices and/or component(s). Further, the company received approval for purchase of certain Plant & Machinery from Vitromed Healthcare, Jaipur, for use in the manufacture of Medical Device(s)/Component(s).

Poly Medicure was established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price.

Poly Medicure Share Price

1468.25 -28.90 (-1.93%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 534.85
Poly Medicure 1468.25
Laxmi Denta 195.10
Nureca Ltd. 263.80
Hemant Surgical Inds 297.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×